0
Leutetium-DOTATATE for Neuroendocrine Tumors
0.00$0.00 SGD
Leutetium-DOTATATE is a form of radioactive targeting therapy that combines DOTATATE, a somatostatin analogue and the radionuclide is Leutetium-177. When the medication is infected into the blood stream, the drug homes in to the neuroendocrine tumor and upon binding to the cancer cell, the leutetium177 will release radiation to kill the cancer cells.
Share this product:
Related Tests
0.00$0.00 SGD
0.00$0.00 SGD
0.00$0.00 SGD
0.00$0.00 SGD
0.00$0.00 SGD
0.00$0.00 SGD
0.00$0.00 SGD
0.00$0.00 SGD
Get in Touch With Our Specialists
Our team provides expert, personalized care for you or your loved ones.
